RotaTeq is a live, oral pentavalent vaccine which protects against rotavirus gastroenteritis.
Each 2 mL dose contains the following human-bovine rotavirus reassortants: G1, G2, G3, G4, and P1A (genotype P). The reassortants are propagated in Vero cells using standard tissue culture techniques in the absence of antifungal agents.
The reassortants are suspended in a buffered stabilizer solution. Each vaccine dose contains sucrose, sodium citrate, sodium phosphate monobasic monohydrate, sodium hydroxide, polysorbate 80, cell culture media, and trace amounts of fetal bovine serum. There are no preservatives or thimerosal present.
DNA fragments from porcine circoviruses (PCV) 1 and 2 have been detected in RotaTeq. The source is porcine-derived material used in the manufacture of the vaccine. PCV-1 and PCV-2 are not known to cause disease in humans.